MASCOLO, Annamaria
 Distribuzione geografica
Continente #
EU - Europa 781
NA - Nord America 621
AS - Asia 147
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
OC - Oceania 1
Totale 1.561
Nazione #
US - Stati Uniti d'America 618
IE - Irlanda 350
IT - Italia 152
GB - Regno Unito 82
VN - Vietnam 67
DE - Germania 61
CN - Cina 54
UA - Ucraina 52
GR - Grecia 24
FI - Finlandia 16
TR - Turchia 16
SC - Seychelles 7
SE - Svezia 7
IN - India 6
PL - Polonia 6
BE - Belgio 5
DK - Danimarca 5
FR - Francia 4
NL - Olanda 4
AT - Austria 2
BR - Brasile 2
CA - Canada 2
ES - Italia 2
EU - Europa 2
HR - Croazia 2
ID - Indonesia 2
RS - Serbia 2
BG - Bulgaria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
IR - Iran 1
JP - Giappone 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RU - Federazione Russa 1
Totale 1.561
Città #
Dublin 347
Chandler 113
Jacksonville 88
Dong Ket 60
Princeton 40
Roxbury 39
Bremen 35
Ashburn 29
Naples 28
Medford 26
Beijing 23
Cambridge 15
Ann Arbor 13
Wilmington 12
Aversa 10
Caserta 10
New York 10
Boardman 8
Des Moines 8
Napoli 8
Woodbridge 8
Hanoi 7
Milan 7
Düsseldorf 6
Nanjing 6
Wroclaw 6
Bologna 5
Brussels 5
Hanover 5
Juelsminde 5
Kunming 5
Redwood City 5
Arezzo 4
Auburn Hills 4
Dallas 4
Helsinki 4
Lamezia Terme 4
London 4
Norwalk 4
Padova 4
Groningen 3
Lappeenranta 3
Pomigliano d'Arco 3
Ardea 2
Boydton 2
Carife 2
Changsha 2
Dearborn 2
Gosport 2
Guangzhou 2
Hebei 2
Krems 2
La Jolla 2
Mele 2
Rome 2
Salerno 2
San Giorgio 2
Shenyang 2
West Jordan 2
Zagreb 2
Amsterdam 1
Arienzo 1
Belogradchik 1
Beograd 1
Brescia 1
Brno 1
Calitri 1
Capri 1
Castellammare di Stabia 1
Cedar Knolls 1
Cerasomma 1
Cerveteri 1
Chongqing 1
Cincinnati 1
Duncan 1
Dunedin 1
Gualtieri 1
Guido 1
Haikou 1
Jiaxing 1
Jinan 1
Kragujevac 1
Los Angeles 1
Madrid 1
Manaus 1
Marano Di Napoli 1
Messina 1
Mountain View 1
Nanning 1
Oslo 1
Ottawa 1
Pagani 1
Paris 1
Portland 1
Portsmouth 1
Pune 1
Saint Paul 1
San Juan 1
San Mateo 1
Sant'Antimo 1
Totale 1.107
Nome #
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review 76
Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy 74
Campania preventability assessment committee (Italy): A focus on the preventability of non-steroidal anti-inflammatory drugs' adverse drug reactions 74
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 73
Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation? 64
Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions 55
Effect of chronic kidney diseases on mortality among digoxin users treated for non-valvular atrial fibrillation: A nationwide register-based retrospective cohort study 53
Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases 52
A case of figurate urticaria by etanercept 51
Comparison of long-term clinical implications of beta-blockade in patients with obstructive airway diseases exposed to beta-blockers with different β1-adrenoreceptor selectivity: An Italian population-based cohort study 47
New and old roles of the peripheral and brain renin–angiotensin–aldosterone system (RAAS): Focus on cardiovascular and neurological diseases 45
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system 45
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting( 43
The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study 41
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 39
Correction to: Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation? (Heart Failure Reviews, (2020), 10.1007/s10741-020-09961-9) 38
Current and future therapeutic perspective in chronic heart failure 37
Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System 34
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study 33
Relationship between gender and the effectiveness of montelukast: An Italian/Danish register-based retrospective cohort study 32
Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article 28
Contribution of Italian clinical research for contrast media-induced nonrenal adverse drug reactions over the last three decades: A systematic review 28
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 28
Preliminary results of the FASM study, an on-going italian active pharmacovigilance project 28
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System 26
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 26
The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis 26
Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: A Danish nationwide cohort study 25
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 25
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary 24
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 24
The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs. 24
Therapeutic strategies to fight COVID-19: Which is the status artis? 24
European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events 23
Preventable cases of oral anticoagulant-induced bleeding: Data from the spontaneous reporting system 22
Suspected adverse reactions to contrast media in Campania Region (Italy): Results from 14 years of post-marketing surveillance 22
Renin-angiotensin system and coronavirus disease 2019: A narrative review 22
Response to the comment “Is SGLT2i superior to DPP4i for primary and secondary prevention of cardiovascular diseases and death in patients with type 2 diabetes?” 22
Pillars and Pitfalls of the New Pharmacovigilance legislation: Consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors 21
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase ® 21
Response to the comment on “SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies” 19
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance 18
SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies 16
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance 13
Decolonization of drug-resistant Enterobacteriaceae carriers: A scoping review of the literature 13
What Is the Role of Nutraceutical Products in Cancer Patients? A Systematic Review of Randomized Clinical Trials 10
The efficacy and the safety of Eltrombopag in pediatric patients with Severe Aplastic Anemia: a systematic review 10
COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database 9
Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database 9
The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study 8
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? 8
Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL 7
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study 7
Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database 6
Endotoxin: Structure Source and Effects 5
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis 5
Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: Nationwide cohort study 4
The risk of fractures, acute myocardial infarction, atrial fibrillation and ventricular arrhythmia in geriatric patients exposed to promethazine 4
Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study 4
Neutral endopeptidase (neprilysin) 3
Retrospective Analysis of a Real-Life Use of Tixagevimab–Cilgavimab plus SARS-CoV-2 Antivirals for Treatment of COVID-19 1
Totale 1.674
Categoria #
all - tutte 7.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.646


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 0 5 3
2019/2020121 21 18 1 1 14 5 24 9 16 5 6 1
2020/2021220 6 1 18 12 33 8 22 15 5 7 30 63
2021/2022252 2 9 10 2 71 14 8 9 17 14 11 85
2022/2023650 76 28 15 37 54 43 9 26 311 7 27 17
2023/2024266 22 12 19 20 96 19 6 30 28 13 1 0
Totale 1.674